Home » Topics » BioWorld Science

BioWorld Science
RSS

KAND-567 demonstrates positive effect on mobility in a preclinical model of spinal cord injury

June 17, 2020

Phase IIa data reported for Sym-015 in non-small cell lung cancer patients

June 17, 2020

Staten begins first-in-human study of STT-5058 for hypertriglyceridemia

June 17, 2020

Prozac for infectious disease

June 17, 2020

Lifespan synaptic atlas gives developmental insights

June 17, 2020

FDA approves Lyumjev for type 1 and type 2 diabetes

June 16, 2020

Phase IIb study of lanifibranor in NASH meets primary and key secondary endpoints

June 16, 2020

Janssen plans phase II development of JNJ-40411813 for epilepsy

June 16, 2020

FDA grants accelerated approval to Zepzelca for metastatic SCLC

June 16, 2020

Favorable safety, pharmacodynamic activity seen with FT-4202 in phase I study

June 16, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Fauci’s silence may put him in contempt of Congress
BioWorld
After repeatedly invoking the Fifth Amendment to every question asked during the July 29 hearing of the U.S. Senate Homeland Security Committee, Anthony Fauci,...